President Donald Trump on Tuesday announces an agreement with Pfizer to voluntarily sell its medications at lower prices, as his administration pushes to link U.S. drug prices to the cheaper prices paid abroad. Pfizer CEO Albert Bourla will be in attendance, a White House official said. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/42d859g » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC » Watch CNBC on ...

格隆汇9月30日｜据华尔街日报，辉瑞(PFE.US)首席执行官预计将宣布在美国投资700亿美元用于药品生 产。白宫将宣布推出"TRUMPRX"药品购买网站。TRUMPRX将允许人们通过政府网站直接用现金购买 某些药品，并享受政府协商的折扣价。 ...

Watch live coverage as President Trump announces a deal with Pfizer on lowering drug prices. For more context and news coverage of the most important stories of our day, click here: https://www.nbcnews.com » Subscribe to NBC News: http://nbcnews.to/SubscribeToNBC » Watch more NBC video: http://bit.ly/MoreNBCNews NBC News Digital is a collection of innovative and powerful news brands that deliver compelling, diverse and engaging news stories. NBC News Digital features NBCNews.com, MSNBC.com, TODAY.com, Night ...

Group 1 - President Donald Trump will announce that Pfizer plans to lower prices on several of its medications in the United States [1]

Core Points - President Trump is set to announce a deal with Pfizer to voluntarily lower drug prices, linking U.S. prices to those paid abroad [1][2] - The announcement will take place at 11 a.m. ET, with Pfizer CEO Albert Bourla in attendance [2] - Trump previously sent letters to Pfizer and 16 other drugmakers urging them to lower drug prices by September 29, following the revival of the "most favored nation" policy aimed at reducing costs [3]

Group 1 - Pfizer's stock price increased by over 2.3%, reaching $24.4 [1] - President Trump announced a drug pricing agreement with Pfizer, allowing the company to voluntarily sell its drugs at lower prices through the Medicaid program [1]

辉瑞涨幅扩大至3.5%，公司将在美国投资700亿美元用于药品生产。 来源：滚动播报 ...

Core Viewpoint - Pfizer's stock price has increased by over 2.3%, reaching $24.4, following the announcement of a drug pricing agreement with President Trump, which allows the company to sell its medications at lower prices through the Medicaid program [1] Group 1 - Pfizer's stock performance shows a positive market reaction, indicating investor confidence in the company's pricing strategy [1] - The agreement with the U.S. government may enhance Pfizer's market position by making its drugs more accessible to a broader patient population [1] - The announcement reflects ongoing discussions around drug pricing reform in the U.S. healthcare system, which could impact the pharmaceutical industry as a whole [1]

Pfizer to sell drugs at lower prices to US Medicaid under Trump’s ‘most favored nations’ plan, the Washington Post reports https://t.co/lWk28a2x8C ...

President Trump is expected to unveil the measures with Pfizer's CEO on Tuesday ...